Structured evidence table for Fish Oil Reaction Time Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Fish Oil Reaction Time Randomized Trial | This condition is strongly associated with functional decline and increased disability risk, substantially impacting healthcare systems worldwide. | 2 | Yuan Weixia (2026) | Twelve-week combined arginine and fish oil supplementation is associated with reduced sarcopenia severity: a randomized, double-blind, placebo-controlled study |
| Fish Oil Reaction Time Randomized Trial | Key contributing factors include the downregulation of anabolic hormones (insulin, sex steroids, and growth hormone), increased muscle fiber apoptosis, and elevated circulating levels of pro-inflammatory cytokines (–). | 2 | Yuan Weixia (2026) | Twelve-week combined arginine and fish oil supplementation is associated with reduced sarcopenia severity: a randomized, double-blind, placebo-controlled study |
| Fish Oil Reaction Time Randomized Trial | 15 16 17 18 21 Emerging evidence suggests a synergistic relationship between fish oil and arginine, with studies demonstrating that fish oil can enhance arginine bioavailability and activity (,). | 2 | Yuan Weixia (2026) | Twelve-week combined arginine and fish oil supplementation is associated with reduced sarcopenia severity: a randomized, double-blind, placebo-controlled study |
| Fish Oil Reaction Time Randomized Trial | 1 2 3 4 5 8 Sarcopenia, a geriatric syndrome characterized by progressive loss of skeletal muscle mass, diminished muscle strength, or impaired physical performance, has emerged as a significant public health concern in aging populations (). | 2 | Yuan Weixia (2026) | Twelve-week combined arginine and fish oil supplementation is associated with reduced sarcopenia severity: a randomized, double-blind, placebo-controlled study |
| Fish Oil Reaction Time Randomized Trial | However, conventional soybean oil-based emulsions, which are rich in omega-6 fatty acids, are associated with a risk of exacerbating pro-inflammatory responses and immunosuppression, which is of particular importance in critically ill patients. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
| Fish Oil Reaction Time Randomized Trial | The cited meta-analyses and clinical studies indicate that omega-3-containing emulsions may reduce the risk of infections and sepsis; shorten hospital stay, ICU length of stay, and duration of mechanical ventilation in patients with sepsis; as well as improve outcomes in acute pancreatitis; lower the risk of delirium; and reduce the incidence of delayed gastric emptying. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
| Fish Oil Reaction Time Randomized Trial | Conclusions Available data support the use of mixed-oil ILE supplemented with fish oil in the parenteral nutrition of critically ill patients as a strategy with immunomodulatory and pro-resolving potential that may translate into improved clinical outcomes. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
| Fish Oil Reaction Time Randomized Trial | Background and aims Injectable lipid emulsions are an integral component of parenteral nutrition, providing energy as well as essential fatty acids. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
Source documents